Protara Therapeutics, Inc. (TARA)

CIK 1359931 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Protara Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 13, 2026SCHEDULE 13G/A0001274173-26-000205
Aug 11, 2026S-80001213900-26-087781
Aug 11, 20268-K0001213900-26-087506
Aug 11, 202610-Q0001213900-26-087508
Jul 7, 2026SCHEDULE 13G/A0001104659-26-081389
Jul 1, 202640001213900-26-074238
Jun 29, 20261440001950047-26-006626
Jun 29, 20268-K0001213900-26-073184
Jun 16, 202640001213900-26-069245
Jun 16, 202640001213900-26-069249
Jun 16, 202640001213900-26-069246
Jun 16, 202640001213900-26-069247
Jun 16, 202640001213900-26-069244
Jun 16, 202640001213900-26-069250
Jun 16, 202640001213900-26-069243
Jun 16, 202640001213900-26-069248
Jun 15, 20268-K0001213900-26-068774
Jun 3, 202640001213900-26-064792
May 28, 2026424B50001213900-26-062153
May 22, 2026EFFECT9999999995-26-001748
May 15, 2026SCHEDULE 13G/A0001274173-26-000151
May 14, 2026S-30001213900-26-056057
May 13, 20268-K0001213900-26-055462
May 13, 202610-Q0001213900-26-055463
Apr 28, 2026DEFA14A0001213900-26-048556